Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$49.79 - $68.85 $946 - $1,308
-19 Reduced 13.19%
125 $8,000
Q1 2024

May 14, 2024

BUY
$51.15 - $56.52 $7,365 - $8,138
144 New
144 $7,000
Q2 2023

Aug 14, 2023

BUY
$52.61 - $59.54 $52 - $59
1 Added 1.06%
95 $6,000
Q1 2023

May 22, 2023

BUY
$51.83 - $79.63 $4,612 - $7,087
89 Added 1780.0%
94 $5,000
Q1 2023

May 15, 2023

SELL
$51.83 - $79.63 $4,612 - $7,087
-89 Reduced 94.68%
5 $9,000
Q4 2022

Feb 15, 2023

BUY
$58.4 - $75.53 $1,343 - $1,737
23 Added 32.39%
94 $7,000
Q3 2022

Nov 15, 2022

BUY
$55.32 - $67.54 $221 - $270
4 Added 5.97%
71 $4,000
Q4 2021

Mar 09, 2022

SELL
$62.62 - $79.92 $250 - $319
-4 Reduced 5.63%
67 $5,000
Q2 2021

Aug 23, 2021

SELL
$61.85 - $77.53 $371 - $465
-6 Reduced 7.79%
71 $5,000
Q3 2020

Nov 30, 2020

BUY
$45.26 - $57.82 $3,485 - $4,452
77 New
77 $5,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.